HORMONE RECEPTOR NEGATIVE TUMOR
Clinical trials for HORMONE RECEPTOR NEGATIVE TUMOR explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR NEGATIVE TUMOR trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR NEGATIVE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New precision approach aims to wipe out breast cancer before surgery
Disease control Recruiting nowThis Phase 2 trial at Fudan University tests several targeted drug combinations given before surgery for early-stage breast cancer. The goal is to see which combinations best eliminate all signs of cancer (pathological complete response) based on each tumor's specific subtype. Ab…
Matched conditions: HORMONE RECEPTOR NEGATIVE TUMOR
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Breast cancer trial aims to match drugs to tumors for personalized care
Knowledge-focused Recruiting nowThis study is testing new drug combinations for breast cancer to see which ones work best for different tumor types. It involves up to 5,000 people with early-stage or locally advanced breast cancer. Researchers use MRI scans and tissue samples before surgery to predict treatment…
Matched conditions: HORMONE RECEPTOR NEGATIVE TUMOR
Phase: PHASE2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC